PHR — Pharmena SA Income Statement
0.000.00%
Last trade - 00:00- PLN48.23m
- PLN37.58m
- PLN0.30m
Annual income statement for Pharmena SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11.1 | 9.93 | 15.2 | 0.299 | 0.299 |
| Cost of Revenue | |||||
| Gross Profit | 7.4 | 5.08 | 7.83 | 0.091 | -0.001 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 21.4 | 15.9 | 19.2 | 4.35 | -32.6 |
| Operating Profit | -10.3 | -6.01 | -3.98 | -4.05 | 32.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -10.7 | -6.27 | -4.46 | -4.95 | 32.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9.57 | -6.96 | -4.64 | -5.16 | 27 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -9.43 | -6.89 | -4.59 | -1.57 | 28.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.43 | -6.89 | -4.59 | -1.57 | 28.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.928 | -0.624 | -0.403 | -0.454 | 2.44 |
| Dividends per Share |